PRTX-100: Clinical Trials

3 trials of PRTX-100, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 2, Completed 1
Phase 23Terminated 2, Completed 1

Follow PRTX-100: new trials by email Literature Review of PRTX-100 trials Research Report on PRTX-100

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP
PRTX-100 - Immune Thrombocytopenia
Phase 1 / Phase 2TerminatedProtalex, Inc.152015-11-012019-03-25
PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP
PRTX-100 - Immune Thrombocytopenia
Phase 1 / Phase 2TerminatedProtalex, Inc.132015-09-012019-07-05
6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection
PRTX-100 - Arthritis, Rheumatoid
Phase 1 / Phase 2CompletedProtalex, Inc.132015-02-012018-10-16

Conditions studied

Purpura, Thrombocytopenic, Idiopathic (2)  ·  Thrombocytopenia (2)  ·  Arthritis, Rheumatoid (1)

Sponsors

Protalex, Inc. (3)

Countries

United Kingdom (2)  ·  United States (2)  ·  France (1)

Top investigators

John B McClain, MD (1)  ·  William E Gannon Jr., MD (1)  ·  William E Gannon, MD (1)

NIH funding

2014 (1)